DuPont: Building Higher Growth, Higher Value Through Science Douglas Muzyka, Ph.D. Senior Vice President; Chief Science & Technology Officer

Transcription

1 DuPont: Building Higher Growth, Higher Value Through Science Douglas Muzyka, Ph.D. Senior Vice President; Chief Science & Technology Officer

2 Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the company and allows investors to better evaluate the financial results of the company. These measures should not be viewed as an alternative to GAAP measures of performance. Furthermore, these measures may not be consistent with similar measures provided by other companies. This data should be read in conjunction with previously published company reports on Forms 10-K, 10-Q, and 8-K. These reports, along with reconciliations on non-gaap measures to GAAP are available on the Investor Center of under Key Financials & Filings. Forward Looking Statements During the course of this presentation we may make forward-looking statements or provide forward-looking information. All statements that address expectations or projections about the future are forward-looking statements. Some of these statements include words such as plans, expects, will, anticipates, "believes," intends, and estimates. Although they reflect our current expectations, these statements are not guarantees of future performance, but involve a number of risks, uncertainties, and assumptions. Some of which include: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; global economic and capital markets conditions; litigation and environmental matters; changes in laws and regulations or political conditions; business or supply disruptions; ability to protect and enforce the company s intellectual property rights; successful integration of acquired business and separation of underperforming or non-strategic assets; and successful completion of the proposed spinoff of the Performance Chemicals segment including ability to fully realize the expected benefits of the proposed spinoff. The company does not undertake to update any forward-looking statements as a result of future developments or new information. Developing Markets Total developing markets is comprised of Developing Asia, Developing Europe, Middle East & Africa, and Latin America. A detailed list of all developing countries is available on the Earnings News Release link on the Investor Center website at 2 2

3 Our Purpose DuPont is a Science Company We work collaboratively to find sustainable, innovative, marketdriven solutions to solve some of the world s biggest challenges, making lives better, safer, and healthier for people everywhere. National Geographic image 3

4 Three Strategic Priorities Drive the Value of DuPont AG & NUTRITION INDUSTRIAL BIOSCIENCES ADVANCED MATERIALS Extend leadership across high-value, science-driven segments of the Ag and Food value chain Develop world-leading industrial biotech capabilities to create new businesses Grow leading position in differentiated highvalue materials Higher Growth, Higher Value Company Through Three World-Leading Positions 4

5 Together with Three Key Operational Priorities INNOVATION GLOBAL REACH EXECUTION Rigorous pipeline management Disciplined project execution Increasing return on R&D Driving penetration in fast-growing, developing markets Delivering ongoing productivity Optimizing resource allocation Returning cash to shareholders 5

6 Driving Innovation: Our Approach 6

7 Translating Science into Solutions WORLD CLASS INTEGRATED SCIENCE COUPLED WITH COMPELLING MARKET INSIGHTS TO SOLVE WORLD SCALE CHALLENGES FOOD Integration of emerging biological sciences ENERGY PROTECTION Engineering Materials Science Chemistry Biological Sciences Engineering Chemistry Materials Science Biological Sciences DuPont is on the Forefront of Another Wave of Innovation 7

8 Global Collaboration and Customer Engagement Drive Growth Innovation centers are the gateway to solving customer challenges Localized market visibility and technical expertise Engagement with customers and ongoing collaboration globally Accelerates innovation and sharing of DuPont s rich scientific portfolio with a global customer base R&D Center Innovation Center A World Class Infrastructure to Bring DuPont Science to Market 8

9 Disciplined Project Management Ensures Alignment Between Science and Integrated Business Innovation Processes Stage 0 Governance & Project Execution Technology Marketing Insights Brand Ideas & Opportunity Choices Launch Management Innovation Portfolio Management 9

10 Increasing our Return on R&D Key Aspects of Measurement Process Segmentation of R&D spend into 4 categories Strict financial rigor behind top R&D programs expected to drive growth Calculation of projected returns on top R&D programs Metrics package & dashboards to assess current state against commitments Frequent interactions with business leadership to update progress Discovery and Major Growth R&D Distribution Sustain and Incremental Growth Disciplined and Rigorous Process to Measure and Improve Return on R&D 10

11 DuPont has a Strong and Balanced Pipeline: Examples of Major Projects Discovery Development Launch Automotive TPC Bio-Isoprene Corn: New MOA Insect Control Kevlar Tire Innovation Bio-THF Probiotics Zytel Next Gen Nylons Personal Care Enzymes Biobutanol Cold H2O Enzymes Food Protection Silicon Ink OLED Cellulosic Ethanol Cyazypyr Plenish PV: Ionomer Encapsulant AcreMax Seed Treatment Corn: Intrasect Canola PV: Front side silver paste Kevlar AP Agriculture and Nutrition $0-100MM $100MM- 500MM $500MM+ Bio-based Industrials Advanced Materials Application of DuPont Science to World Scale Challenges is a Significant and Sustainable Competitive Advantage Note: Circle size indicates estimated peak year revenue 11

12 Putting Science to Work: Where we are Today 12

13 Portfolio Enhancements Safety & Protection 2013 Segment Sales Industrial Biosciences Agriculture Performance Coatings Performance Materials $36 B* Electronics & Communications Performance Chemicals Nutrition & Health Higher Value Creation Going Forward * Consolidated net sales from continuing operations. 13

14 DuPont Science is Embedded in All of our Business Segments and Forms the Basis for Value Creation Industrial Biosciences Performance Materials Particle & Dispersion Science Catalysis Precision Patterning Fiber Science & Engineering Fluoro Chemical & Polymer Synthesis Polymer Synthesis Surface & Colloidal Science Film Fabrication Inorganic / Organic Synthesis Rheology Control Inorganic- Organic Composites Polymer Processing Electronics & Communications Biochemistry Fermentation Engineering Formulation Science Nanoscience Metabolic Engineering Nutrition Science Molecular Biology Chemical Engineering Agronomy Plant Physiology/ Disease Microbiology Conventional Breeding Gene Recombination & Regulation Cell / Tissue Culture Protein Engineering Molecular Breeding Genomics Bioinformatics Entomology Agriculture Nutrition & Health Plant Genetics Safety & Protection DuPont Integrated Science Creates a Competitive Advantage 14

15 Science is the Growth Engine for the Company Agriculture & Nutrition Industrial Biosciences Advanced Materials Seeds Traits Crop Protection Specialty Food Ingredients Enzymes Biomaterials Biofuels Biochemicals Electronic Materials Protective Materials Alternative Energy Advanced Polymers Advanced Processes $ 5.8B* new product revenue $ 0.4B* new product revenue $ 3.9B* new product revenue *2013 revenue from products introduced in the last four years 15

16 Copyright 2014 DuPont. All rights reserved. The DuPont Oval Logo, DuPont TM, The miracles of science TM, and all products denoted with or M are trademarks or registered trademarks of E. I. du Pont de Nemours and Company.